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Objective: Atrial fibrillation is the most frequently encountered postoperative ar-
rhythmic complication after coronary artery bypass grafting. Ischemic precondition-
ing has proved a potent endogenous factor in suppressing ischemia-reperfusion–
induced arrhythmias. The protective effect of ischemic preconditioning on atrial
fibrillation after coronary artery bypass grafting has not been studied. The purpose of the
present study was to investigate whether ischemic preconditioning had an effect on
postoperative atrial fibrillation in patients undergoing coronary artery bypass grafting.
Methods: Eighty-five patients undergoing coronary artery bypass grafting were
randomized into ischemic preconditioning and control groups. Holter data from
24-hour electrocardiography were collected 1 day before the operation to the second
postoperative day. Atrial fibrillation was registered as positive if any atrial fibrilla-
tion event occurred.
Results: The overall incidence of postoperative atrial fibrillation and sustained atrial
fibrillation was 34.1% and 27.1%, respectively. The occurrence of atrial fibrillation
was significantly lower in the ischemic preconditioning group (21.4% in patients
undergoing ischemic preconditioning and 46.5% in control subjects, P  .015).
Preoperative recent unstable angina did not influence the incidence of atrial fibril-
lation. Patients with atrial fibrillation had longer intensive care unit stays and
compromised postoperative hemodynamic outcomes. Binary logistic regression
analysis showed that ischemic preconditioning, preoperative mean heart rate, and
postoperative pulmonary capillary wedge pressure were the independent predictors
of atrial fibrillation.
Conclusions: Postcoronary artery bypass grafting atrial fibrillation is associated with
more complicated postoperative outcome. Higher preoperative heart rate and post-
operative pulmonary capillary wedge pressure were the independent predictors of
atrial fibrillation. Recent unstable angina is not related to the occurrence of post-
coronary artery bypass grafting atrial fibrillation. Ischemic preconditioning signif-
icantly suppresses postcoronary artery bypass grafting atrial fibrillation, suggesting
that ischemic preconditioning can be used as an effective prophylactic method for
postoperative atrial fibrillation.
Atrial fibrillation (AF) is the most frequently encountered postop-erative arrhythmic complication associated with coronary arterybypass grafting (CABG).1-9 Although rarely fatal, post-CABG AFmight lead to subjective discomfort and anxiety, systemic embo-lization, iatrogenic complication, compromised hemodynamicfunction, hypotension, pulmonary edema, heart failure, longer
hospitalization, and need for posthospital medication use. AF is also associated with
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increased 30-day and 6-month mortality and increased total
cost of medical care.1-4,8,9 Many complications of coronary
artery bypass surgery occur more often in patients who have
postoperative AF than in patients who do not.1 Moreover,
treatment of AF might fail or might be associated with
potentially harmful side effects, such as the proarrhythmic
effects of antiarrhythmic drugs, bleeding from anticoagula-
tion, and recurrent hospital admission.2,3,8 Research for a
suitable means of preventing post-CABG AF is thus clearly
warranted.
Myocardial ischemic preconditioning (IP) has been ex-
tensively studied in various kinds of experimental models,
as well as in human subjects.10-21 The approach has proved
a potent endogenous factor in preserving high-energy phos-
phates, delaying myocardial infarction, and improving post-
ischemic functional recovery.10-13 Myocardial precondition-
ing in experimental animals has been reported to be
associated with decreased postischemic reperfusion arrhyth-
mias, with these effects being apparently as potent as those
induced with standard antiarrhythmic drugs.14-16 There is
also evidence that IP suppresses both ventricular17-19 and
atrial19-21 arrhythmias in the human heart. Whether IP pro-
tects the heart from postoperative AF in cardiac surgery has
not been studied. The present purpose was to investigate
whether IP had an effect on postoperative AF in patients
with stable and unstable angina pectoris undergoing CABG.
Methods
The study design was accepted by the Ethical Committee of
Tampere University Hospital, Finland, and informed consent was
obtained from all patients.
Eighty-nine consenting stable and unstable patients undergoing
CABG were randomized into 2 groups: a control group and a study
group receiving the IP protocol. All unstable patients had unstable
angina pectoris within 3 days before the operation. This was
diagnosed by means of electrocardiography (ECG) and treated
with nitroglycerine infusion. Patients with recent myocardial in-
farction (3 months previous), the presence of preoperative basic
rhythm of AF, previous diagnosed paroxysmal AF, additional
cardiac diseases (eg, valvular disease), severe noncardiac diseases
(eg, pulmonary hypertension and renal failure), cardiac redo op-
erations, and emergency operations were excluded from the study
cohort.
Two patients in the control group and one in the IP group were
excluded because of unnoticed accidental disconnection of the
wires or malfunction of the Holter recording apparatus during
24-hour ECG. One IP group patient with preoperative basic
rhythm of AF during the 24-hour ECG monitoring was also
excluded from the study. This left a final study cohort of 85
patients (42 patients in the IP group and 43 patients in the control
group). The preoperative characteristics of the patients in the
respective groups were similar (Table 1).
Preconditioning Protocol
Cardiopulmonary bypass (CPB) was established, and the heart was
vented. The aorta was then crossclamped for 2 minutes, followed
by 3 minutes of reperfusion. The control group also had the pump
running for 10 minutes before the routine operation.
Anesthesia, CPB, and Surgical Technique
A standardized anesthetic technique was used with sufentanil (7.8
g/kg), midazolam (0.10-0.125 mg/kg for induction and 0.20
mg/kg for maintenance), and pancuronium (0.22 mg/kg).
CPB with nonpulsatile perfusion flow (2.2-2.4 L · min1 · m2)
was conducted by using membrane oxygenators with arterial line
filtration. Mild hypothermia (32°C) was maintained without topi-
cal cooling. Surgical techniques were the same in all cases. Aortic
root and 2-stage single venous cannulas were used for CPB. A
retrograde, self-inflating coronary sinus cardioplegia cannula
(RC014; Research Medical Inc) with a pressure-monitoring port
was guided into place. A 9-gauge cannula was placed in the aortic
root for antegrade cardioplegia or for venting. Distal anastomoses
were made in the order of right coronary artery–circumflex artery–
left anterior descending artery, and proximal anastomoses were
constructed during crossclamping. Left internal thoracic artery to
left anterior descending artery grafting was used in all patients.
Blood from the pump reservoir was mixed with crystalloid in a
ratio of 4:1, yielding a cardioplegia solution with a 21% hematocrit
value and 21 mmol/L potassium concentration in the initial dose
and 9 mmol/L in subsequent doses. During antegrade delivery
cardioplegia was administered at a pressure of 80 mm Hg and





(n  43) P value
Preoperative transient AF 2 (4.8) 2 (4.7) .981
Age (y) 64.6 9.5 65.9 9.2 .534
Sex (n female) 10 (23.8) 11 (25.6) .850
Unstable 20 (47.6) 21 (48.8) .911
Left ventricular ejection
fraction
60.3 11.2 63.0 9.8 .247
NYHA classification 3.5 0.7 3.4 0.6 .805
Infarct history (3 mo) 21 (50.0) 18 (41.9) .451
Diabetics 9 (21.4) 15 (23.3) .746
Risk factor (Cleveland model) 1.7 1.8 1.5 1.6 .551
Preoperative use of -
blocker
38 (90.5) 39 (90.7) .972
Preoperative use of
amiodarone
1 (2.4) 1 (2.3) .987
Preoperative use of ACE
inhibitor
9 (21.4) 9 (20.9) .955
Preoperative use of Ca
antagonist
13 (31.0) 12 (27.9) .758
Left main stenosis 50% 14 (33.3) 14 (32.6) .939
Aortic crossclamping time
(min)
80.6 17.8 78.3 20.0 .570
Perfusion time (min) 112.9 20.9 108.3 19.0 .302
No. of bypasses 3.8 0.8 3.7 0.8 .292
Preoperative transient AF was recorded during preoperative Holter mon-
itoring. Continuous data are presented as means SD, and categoric data
were recorded as numbers of patients (%). NYHA, New York Heart Asso-
ciation; ACE, angiotensin-converting enzyme.
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during retrograde delivery at a pressure of 30 to 50 mm Hg, with
a flow of at least 200 mL/min. The initial high-potassium cardio-
plegia was given 1.5 minutes antegrade and then 2.5 minutes
retrograde at a temperature of 6°C to 9°C. One minute of cardio-
plegia was given retrograde to right coronary artery and left
circumflex artery area grafts after each distal anastomosis. Warm
cardioplegia (37°C) was given retrograde for 3 minutes before
release of crossclamping.
Measurements of AF
Data from 24-hour ECG were collected 1 day before the operation
and immediately after the operation until the second postoperative
day (POD). Recordings of 24-hour ECG were performed with
2-channel tape recorders (Oxford Medilog MR 4500-3). The re-
cordings were analyzed with Oxford Medilog Holter Management
System Excel 2 software (release 8.5). Software-analyzed classi-
fications of QRS complexes and events were checked on the
computer screen and corrected manually. The analysis was blind to
the investigators. The data were preserved and analyzed in the
same period with the same standard.
AF was defined as an irregular narrow complex rhythm with
absence of discrete P waves. AF was registered as positive if any
AF event appeared for longer than 30 seconds. AF episodes of
longer than 10 minutes were defined as sustained AF.
Hemodynamics
Hemodynamic data, including cardiac index and pulmonary cap-
illary wedge pressure (PCWP), were collected at 4 time points: (1)
baseline, before induction of anesthesia; (2) 1 hour after declamp-
ing; (3) 6 hours after declamping; and (4) on the first POD. All
measurements on the basis of the thermodilution technique were
made at end expirium in triplicate with ice-cold saline. The mean
value of 3 consecutive measurements at each time point was
registered.
Postoperative Care
Volume infusion was aimed to maintain the filling pressure at least
at the preoperative level. Pharmacologic therapy with inotropes
was used to keep the cardiac index at greater than 2.0 L · min1
m2; this was not interrupted at the time points when hemody-
namic data were taken. Dopexamine or adrenaline was used as the
first-choice inotrope, and amrinone with noradrenaline was used if
necessary. Electrolytes and acid-base balance were kept in the
normal range. -Blockers were used for all patients after weaning
from the respirator. The cardiologist on duty undertook AF inter-
vention, including medication and electrocardioversion, whenever
needed. Electrocardioversion was used when amiodarone and fle-
cainide failed. The intensive care unit (ICU) team and cardiologists
were blinded in the management of postoperative care.
Statistical Methods
The unpaired Student t test was used for continuous data (2-tail),
and the 2 or Fisher exact tests were used for categoric data when
comparing variables between the groups. The Mann-Whitney U
test was used for skewed distributions. Repeated-measures analy-
sis of variance was used to test repeated observation variables after
the operation. Baseline values were used as a covariant when
appropriate in the analysis. Variables such as IP and patient’s age,
sex, heart rate (HR), PCWP, preoperative and postoperative med-
ication, cardiac function, CPB, and crossclamping periods were
entered for binary logistic regression backward likelihood ratio
analysis to assess the independent predictors for AF. Continuous
data were presented as means  SD, and categoric data were
presented as numbers of patients, with percentages in parentheses.
The statistical analyses were performed with an SPSS/Win (ver-
sion 10.0) statistical package program.
Results
AF episodes
Recordings of 24-hour ECG were maintained for 13.6 3.1
and 14.1  2.4 hours in the IP and control groups preop-
eratively (P  .376), 21.2  1.1 and 21.0  1.8 hours on
the first POD (P  .405), and 23.3  2.5 and 23.5  1.8
hours on the second POD (P  .687) for a total of 44.3 
2.1 and 44.5 2.6 hours postoperatively, respectively (P
.856).
There were 4 patients, 2 in the IP group and 2 in the
control group, with preoperative transient episodes of AF
that lasted from 30 seconds to 4 minutes.
The overall incidences of postoperative AF and sustained
AF were 34.1% and 27.1%, respectively. The onset of AF
was 21.4% on the first POD and 16.5% on the second POD.
In patients with AF, the mean period was 67.2  81.6
minutes (1.0-240 minutes) on tape 2 and 202.9  213.9
minutes (30-759 minutes) on tape 3. Most of the AF epi-
sodes appeared once. There were only 4 patients with 2
episodes of AF; the first episode usually passed within 5
minutes.
IP resulted in significantly less post-CABG AF. Sus-
tained AF after the operation was also significantly sup-
pressed in the IP group. The duration of AF episodes in the
IP group was significantly decreased (Table 2).
Outcome of Surgical Intervention
IP resulted in better postoperative hemodynamic recovery.
The period of mechanical ventilation was significantly
shorter in the IP group than in the control group. The length
of stay in the ICU was similar in both groups. More patients
in the IP group were free of inotropes, and the period of
inotropic medication use was also marginally shorter in the
IP group than in the control group (Table 2). There was no
perioperative myocardial infarction or early postoperative
death. Intra-aortic balloon pumps were not required in any
patients.
AF Predictors and Postoperative Outcome
Post-CABG AF was not related to the patient’s age, sex,
preoperative left ventricular ejection fraction, New York
Heart Association classification, previous history of myo-
cardial infarction, preoperative risk factors, diabetes, preop-
erative medication, severity of coronary vessel stenosis,
aortic crossclamping period, number of vessels bypassed,
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and postoperative inotropic support. Neither recent unstable
angina pectoris nor preoperative transient AF episodes con-
tributed to postoperative AF. Patients with AF had longer
ICU treatment periods and compromised postoperative he-
modynamic outcomes (Table 3). Binary logistic regression
analysis showed that without IP (P  .013), higher preop-
erative HR (P  .035) and higher PCWP on the first POD
(P  .047) were the independent predictors of AF.
Discussion
There is evidence that IP reduces the incidence of ischemia-
reperfusion–induced arrhythmias and results in more nor-
mal sinus rhythm in animal models and in human sub-
jects.14-21 Whether IP reduces ischemia-reperfusion–
induced AF has not been investigated. In the present study
IP significantly reduced the incidence and severity of AF
after CABG. This protective effect was not related to myo-
cardial ischemia measured on the basis of creatine kinase
MB levels. Thus the protective anti-AF effect was not
related to the anti-ischemic protection other than as a direct
consequence of IP.18 IP also resulted in less AF intervention
and better postoperative outcome. The present results sup-
ported the previous findings that atrial arrhythmias can be
reduced by IP.19-21
The present findings showed that AF is a common com-
plication after CABG. AF was also associated with com-
promised postoperative hemodynamic outcome and longer
ICU treatment time. Patients with AF tended to be related to
greater need for inotropic support, postoperative amioda-
rone medication, and longer mechanical ventilation periods.





(n  43) P value
Postoperative AF 9 (21.4) 20 (46.5) .015
Postoperative sustained AF 5 (11.9) 18 (41.9) .002
AF period (min) 20.7 65.3 74.0 165.7 .010
Respiratory treatment (h) 12.2 3.5 18.4 17.5 .028
ICU stay (h) 35.1 25.0 41.3 32.2 .323
Inotropes 23 (54.8) 33 (76.7) .033
Inotropic period (h) 10.1 10.9 18.2 24.2 .057
Peak CK-MB 22.0 10.3 22.0 10.0 .984
Postoperative use of
amiodarone
3 (7.1) 5 (11.6) .479
Postoperative use of
flecainide
1 (2.4) 1 (2.3) .987
Postoperative
electrocardioversion
0 (0) 2 (4.7) .494
CI (baseline, L · min1 ·
m2)
2.54 0.41 2.60 0.55 .016
CI (1 h, L · min1 · m2) 2.69 0.56 2.34 0.59
CI (6 h, L · min1 · m2) 3.22 1.01 2.85 0.89
CI (first POD, L · min1 ·
m2)
3.23 0.78 3.11 0.75
Continuous data are presented as means  SD, and categoric data are
presented as numbers of patients (%). CK-MB, Creatine kinase MB; CI,
cardiac index.




(n  56) P value
Unstable 16 (55.2) 25 (44.6) .357
Age (y) 66.1 8.5 64.8 9.9 .544
Age 65 20 (37.7) 33 (62.3) .365
Age 65 9 (28.1) 23 (71.9)
Sex (n of female) 11 (29.7) 15 (18.8) .184
Left ventricular ejection
fraction
63.1 9.8 60.9 10.9 .364
NYHA 3.5 0.6 3.4 0.7 .388
Preoperative transient AF 1 (3.4) 3 (5.4) .694
Infarct history 13 (44.8) 26 (46.4) .888
Diabetics 4 (14.8) 15 (27.8) .194
Risk factor (Cleveland model) 1.8 2.0 1.5 1.5 .376
Preoperative use of -
blocker
27 (93.1) 50 (89.3) .568
Preoperative use of ACE
inhibitor
7 (24.1) 11 (19.6) .631
Preoperative use of Ca
antagonist
8 (27.6) 17 (30.4) .790
Left main stenosis 50% 11 (37.9) 17 (30.4) .481
Crossclamping time (min) 79.6 25.3 79.4 14.8 .967
Perfusion time (min) 108.3 22.1 111.9 19.0 .416
No. of bypasses 3.7 0.9 3.8 0.8 .642
Respiratory treatment (h) 17.1 10.4 14.3 13.7 .094
ICU (h) 49.7 36.2 32.3 22.5 .011
Peak CK-MB 23.0 11.0 19.9 7.7 .199
Postoperative use of
amiodarone
5 (17.2) 3 (5.4) .075
Inotropes 22 (73.0) 34 (50.0) .163
Inotropic period (h) 16.6 16.3 12.8 20.1 .116
Preoperative mean HR
(beats/min)
62.1 9.0 60.2 8.2 .195
Mean HR first postoperative
24 h
84.4 11.3 83.8 17.9
Mean HR second
postoperative 24 h
79.0 12.1 77.1 11.3
PCWP (baseline, mm Hg) 12.7 4.8 12.0 3.1 .360
PCWP (postoperative 1 h,
mm Hg)
11.0 3.8 11.6 2.5
PCWP (postoperative 6 h,
mm Hg)
10.6 3.4 11.8 3.5
PCWP (first POD, mm Hg) 11.4 2.3 10.7 2.7
CI (baseline, L · min1 · m2) 2.59 0.60 2.57 0.44 .019
CI (postoperative 1 h, L ·
min1 · m2)
2.45 0.68 2.55 0.53
CI (postoperative 6 h, L ·
min1 · m2)
2.78 0.92 3.16 0.96
CI (first POD, L · min1 · m2) 2.91 0.76 3.25 0.74
Continuous data are presented as means  SD, and categoric data are
presented as numbers of patients (%). Heart rate was measured with the
Holter recording apparatus. NYHA, New York Heart Association; ACE,
angiotensin-converting enzyme; CK-MB, creatine kinase MB; CI, cardiac
index.
Cardiopulmonary Support and Physiology Wu et al
1480 The Journal of Thoracic and Cardiovascular Surgery ● November 2003
CSP
Pharmacologic prophylactics with the blockers sotalol and
amiodarone are well supported by randomized clinical tri-
als.2,3,8,22 However, there was still a high incidence of AF in
the present study, even with the use of -blockers. The
efficacy and higher costs, more severe side effects, and
more complicated implementation limit the use of sotalol
and amiodarone. The usefulness of nonpharmacologic strat-
egies, such as continuous overdrive atrial pacing through
temporary epicardial electrodes, is currently under investi-
gation.2,3,8,22 A more readily applicable strategy for the
prevention of post-CABG AF would therefore be highly
desirable. The present findings suggest that IP can be used
as an effective prophylactic method for postoperative AF.
The mechanism involved in the IP effect of suppressing
postoperative AF is not known. Studies show that IP re-
duces the inhomogeneity and modifies the ion channels,
preventing the conduction delays necessary for transmural
re-entry and resulting in fewer arrhythmias.15,19-21 Other
authors have suggested that the antiarrhythmic protection
afforded by IP might be mediated by preservation of auton-
omous function.14 The autonomic nervous system has pre-
viously been implicated in both the ignition and perpetua-
tion of AF after CABG.2,7 This implies that the IP effect in
suppressing post-CABG AF might be mediated by preser-
vation of autonomous function.
The IP effects in suppressing post-CABG AF might be a
subsequent result of the other protective effects. Better
hemodynamic recovery, less inotropic support, and shorter
respiratory ventilation might be associated with less
AF.1,2,21 Inotropes might cause the heart to increase its work
output beyond its energy supply. This energetic supply and
demand inequality might impair membrane ionic pumps and
allow the membrane potential to drift upward toward the
threshold, thereby increasing automaticity.2,21 Logistic re-
gression analysis here showed that IP was an independent
predictor of AF. Thus the protective effect against post-
CABG AF seems to be a direct consequence of IP.
The cause of postoperative AF is not well known.8 A
number of factors have been claimed to be associated with
post-CABG AF.1-9,21,23-25 However, large and well-con-
ducted observational studies have yielded conflicting results
on the independent predictive value of these fac-
tors.1,4,5,8,9,23-25 In our study we found higher preoperative
HR and postoperative PCWP values in relation to the oc-
currence of AF. The results were in concordance with those
of one previous report.9 Older age has consistently predicted
a higher incidence of postoperative AF.8 Here we did not
find age to be correlated with AF. Concerning the relatively
small study cohort, only a tendency of relatively lower
postoperative AF occurrence in younger patients was found.
This phenomenon is similar to our previous finding.23 Be-
cause we used -blockers in all patients postoperatively,
their effect could not be shown here. Higher preoperative
HR predisposed to postoperative AF indicated the impor-
tance of -blocker prophylaxis. It has been reported that
myocardial ischemia might predispose to postoperative
AF,23,24 and unstable angina before surgical intervention
might thus be related to more post-CABG AF. The present
study showed that unstable angina was not related to the
incidence of AF, which is similar to the results of 2 previous
studies.5,8 Our study did not support the previous finding
that paroxysmal AF associates with postoperative AF.9 Dif-
ferences in patient selection might account for this differ-
ence.
One limitation is the small population investigated.
Small samples can not be used to derive a satisfactory
statistical analysis of different perioperative variables, pos-
sibly influencing atrial arrhythmogenesis.9 On the other
hand, this did not influence the finding that IP significantly
suppresses postoperative AF. Another limitation is the re-
cording period lasting only 45 hours postoperatively, so as
not to cause inconvenience and discomfort to the patients.
The incidence of AF might be higher and the sensitivity and
specificity for analysis of data would be more appropriate if
the recording time was longer.
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